Ligand Pharmaceuticals (LGND) Return on Invested Capital (QoQ) (2011 - 2025)

Ligand Pharmaceuticals (LGND) Return on Invested Capital (QoQ) (2011 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 Ligand Pharmaceuticals 5.92 Bn 5.14 Bn 48.45 Mn

Historic Data

Download Data
DateValue
Sep 30, 2025 607.00
Jun 30, 2025 276.00
Mar 31, 2025 -1,428.00
Dec 31, 2024 1,214.00
Sep 30, 2024 18.00
Jun 30, 2024 -501.00
Mar 31, 2024 0.00
Dec 31, 2023 0.00
Sep 30, 2023 0.00
Jun 30, 2023 0.00
Mar 31, 2023 0.00
Dec 31, 2022 0.00
Sep 30, 2022 -1.00
Jun 30, 2022 -769.00
Mar 31, 2022 738.00
Dec 31, 2021 17.00
Sep 30, 2021 -1.00
Jun 30, 2021 8.00
Mar 31, 2020 -10.00
Dec 31, 2019 6.00